BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19935377)

  • 1. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
    Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
    Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
    Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Ward KN; Crooks BN; Parker A; Martino R; Shaw PJ; Brinch L; Brune M; De La Camara R; Dekker A; Pauksen K; Russell N; Schwarer AP; Cordonnier C
    Bone Marrow Transplant; 2001 Sep; 28(5):479-84. PubMed ID: 11593321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
    Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
    Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
    Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
    J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
    Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
    J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
    Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
    Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
    Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.
    Hassan IA; Chopra R; Swindell R; Mutton KJ
    Bone Marrow Transplant; 2003 Jul; 32(1):73-7. PubMed ID: 12815481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.
    Anak S; Atay D; Unuvar A; Garipardic M; Agaoglu L; Ozturk G; Karakas Z; Devecioglu O
    Pediatr Pulmonol; 2010 Mar; 45(3):307-11. PubMed ID: 20146398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.